Title: Enhancement of Influenza Gene Expression
Patent Number: 8,227,188
Filed: Sept. 3, 2010
Lead Inventor: Antonin de Fougerolles, Alnylam Pharmaceuticals
“The invention relates to compositions and methods for modulating the expression of influenza viral genes, and more particularly to the down-regulation of influenza viral genes by chemically modified oligonucleotides,” the patent's abstract states.